Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-002262
Filing Date
2022-02-02
Accepted
2022-02-02 20:18:20
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7251
  Complete submission text file 0001437749-22-002262.txt   8971
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIFFUSION PHARMACEUTICALS INC. 1317 CARLTON AVENUE, SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
Cobuzzi Robert Joseph Jr. (Reporting) CIK: 0001799838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 22586002